Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process
Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
